To assess levels of dioxin background contamination and transfer of dioxins from mothers to unborn children and infants, concentrations of polychlorinated dibenzop-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and coplanar-polychlorinated biphenyls (CoPCBs) were measured in human samples from expectant and nursing mothers living in Nara, Japan. The average toxic equivalency quantities (TEQs) of PCDDs/ PCDFs and Co-PCBs from circulating maternal blood, cord blood, placenta, milk taken 3-10 d after delivery, milk taken one month after delivery, and adipose tissue were 26 and 9.3, 15 and 2.3, 31 and 1.2, 16 and 5.4, 18 and 8.8, and 16 and 7.7 pg-TEQ/g-fat, respectively. Among the various PCDD/PCDF congeners, 1,2,3,7,8-PeCDD and 2,3,4,7,8-PeCDF contributed most heavily to the TEQs of all maternal samples. Among the various Co-PCB congeners, 3,3 0 ,4,4 0 ,5-PeCB (#126), 2,3,3 0 ,4,4 0 ,5-HxCB (#156), and 2,3 0 ,4,4 0 ,5-PeCB (#118) contributed most heavily to the TEQs of all maternal samples. But, the concentrations and relative percentages of congeners differed among the various samples, suggesting that congeners showing high toxic equivalency factor accumulate in the placenta.
p-dioxin (2, 3, 7, , the most toxic chemical found to date. 1) PCDDs and PCDFs are inadvertently produced as a result of chemical plant accidents and thermal reactions generated by the incineration of municipal solid waste and industrial waste. [2] [3] [4] PCBs have been used in the production of a number of industrial materials, such as transformers, capacitors, and noncarbon copying paper.
5) The majority of dioxins accumulated in aquatic sediment in Japan are thought to have originated from agricultural chemicals. 6) It is necessary to elucidate the various sources of PCDDs/ PCDFs and Co-PCBs on wildlife exposure. Dioxins cause a wide range of toxic and biochemical alterations in experimental animals, wildlife, and humans, most of which are mediated by the aryl hydrocarbon (Ah) receptor. 7) Guinea pigs are the species most susceptible to the effects of dioxin exposure. Recently, it has been reported that the guinea pig Ah receptor is the closest homolog to the human Ah receptor. 8) This report emphasizes the danger for humans of exposure to dioxins. Dioxins are extremely toxic and accumulate within the food chain due to their high lipophilicity and stability. Food consumption is an important source of dioxin exposure in humans. A number of researchers have concluded that the primary source of dioxin exposure in humans is consumption of animal and fish fat. 9, 10) While dioxin exposure in Europe and America is primarily due to the consumption of meat, eggs, and dairy products, consumption of seafood is a major source of dioxin exposure in Japan. Absorbed dioxins are distributed to organs via the blood. [11] [12] [13] Human samples have been studied in order to determine background levels of contamination in a number of y To whom correspondence should be addressed. Rakuno Gakuen University, 582 Bunkyodai-Midorimachi, Ebetsu, Hokkaido 069-8501, Japan;
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Furthermore, anxiety surrounds the possibility of infant exposure to dioxins via the placenta or maternal milk, due to the known accumulation of dioxins in adipose tissue. Because the fetal period and infancy are important times with regard to development and differentiation, the possibility of exposure to dioxins during this time is particularly of concern. The distribution of dioxins and modes of transmission of dioxins to fetuses and infants have been studied using experimental animals. Hagenmaier et al. 22) have reported transfer of PCDDs and PCDFs via the placenta and milk in the marmoset monkey. Weber and Birnbaum 23) have characterized the distribution of 2,3,7,8-TeCDF within mice dams, placentas, and embryos. Van den Berg et al. 24) have described the disposition of 17 dioxins and furans in maternal liver and adipose tissue, as well as in the fetuses and pup livers of rats. Chen et al. 25) were the first to describe transfer of non-ortho PCBs from maternal rats to their progeny, after which they investigated the pharmacokinetics of various dioxin-like chemicals and their influence on transfer from dam to offspring. These studies have provided significant information with regard to the disposition of dioxins in experimental animals.
On the other hand, there are limited data with regard to the distribution of dioxins in human milk, 14, 16, 18, 20, 21) and even fewer data regarding the distribution of dioxins within the human placenta. 9, 19, 21) It is important to elucidate the distribution and modes of transfer of dioxins to the human fetus and human infants.
The aim of the present study was to assess levels of background contamination in Japan by examining dioxin levels in pregnant females. We also investigated the transfer of dioxins from mothers to unborn children and infants via the placenta and breast milk. This was done by determining dioxin concentrations within maternal blood, cord blood, mother's milk, the placenta, and adipose tissue from pregnant women living in Japan.
Materials and Methods
Participants. This research was conducted with the cooperation of 22 expectant and nursing mothers (24-37 years old) living in Nara Prefecture (the Kansai area), Japan. The study was conducted in accordance with the general principles of the Helsinki Declaration, and all study protocols were reviewed and approved by the Institutional Review Board of Saiseikai Nara Hospital.
Samples. Blood (20 ml) and cord blood (20 ml) samples were collected either immediately after, or within two days of, delivery from expectant and nursing mothers. Their placentas (20 g) were collected after delivery. Samples of adipose tissue (5-10 g) could be obtained only from women who received Caesarean sections, from whom abdominal adipose tissue was collected at the time of the procedure. Maternal milk samples were collected 3-10 d and one month after delivery. Four and five samples of maternal blood were analyzed for PCDDs/PCDFs and Co-PCBs respectively. Sixteen and 22 samples of cord blood were analyzed for PCDDs/PCDFs and Co-PCBs respectively. Twenty-one and 13 placental specimens were analyzed for PCDDs/ PCDFs and Co-PCBs respectively, as were six samples of milk, taken 3-10 d after delivery. Finally, four samples of milk, taken one month after delivery, were analyzed for PCDDs/PCDFs and Co-PCBs, while 20 samples of adipose tissue were analyzed for PCDDs/ PCDFs and 12 were analyzed for Co-PCBs. All samples were refrigerated during transport from Nara Prefecture to Obihiro University and stored at À30 degrees until the time of analysis. Blood and mother's milk: Dioxin-containing lipid was separated from mother's milk by combining it with saturated ammonium sulfate, followed by ethanol, after which the lipid was extracted with n-hexane twice. The pooled n-hexane fraction was then washed twice with a 2% NaCl solution. Following this, the n-hexane layer was dehydrated with Na 2 SO 4 and evaporated. The extracted lipid was weighed. Dioxin-containing lipid was extracted from blood in the same way.
Placenta and adipose tissue: Samples were combined with 50% (v/v) chloroform/methanol, homogenized, and subjected to sonication for isolation of dioxincontaining lipid. The pooled extraction liquid was washed twice with a 2% NaCl solution. The chloroform layer was then dehydrated with Na 2 SO 4 and evaporated. The extracted lipid was weighed.
Cleanup. Cleanup was performed using a multi-layer column composed of Na 2 SO 4 , silica gel, 10% (w/w) AgNO 3 -silica gel, silica gel, 22% (w/w) H 2 SO 4 -silica gel, 44% (w/w) H 2 SO 4 -silica gel, silica gel, 2% (w/w) KOH-silica gel, and silica gel. After elution with 120 ml of n-hexane, the solution was evaporated to a small volume. The concentrate was then applied to an alumina column. The first fraction, which was eluted with 90 ml of 2% (v/v) dichloromethane/n-hexane, contained mono-ortho Co-PCBs. The second fraction, eluted with 120 ml of 50% (v/v) dichloromethane/n-hexane, contained PCDDs/PCDFs and non-ortho Co-PCBs. Then the sample was evaporated. Measurements of PCDDs/PCDFs in maternal samples were carried out as described in ''Materials and Methods''. a Values were calculated at ND (Not detected) = zero, b Calculated using the WHO-TEF for humans.
7)
Quantification and identification of dioxin congeners. Analysis of PCDDs/PCDFs was performed using high resolution gas chromatography/mass spectrometry (HRGC/HRMS) using a HP-6890 (Hewlett Packard, U.S.A.) spectrometer with a SP-2331 fused silica capillary column (60 m Â 0:32 mm i.d., 0.20 mm film thickness, Supelco, U.S.A.). In addition, analysis was performed using a DB-17HT fused silica capillary column (60 m Â 0:32 mm i.d., 0.15 mm film thickness, J and W Scientific, U.S.A.) coupled to an Autospec Ultima (Micromass, U.S.A.) mass spectrometer employing the El (Electron Impact)-SIM (Selected Ion Monitoring) method at 10,000 resolutions. To determine the recovery rate of various PCDDs/PCDFs, mixtures of 13 C-labeled PCDDs/PCDFs were used. Analysis of CoPCBs was performed by HRGC/HRMS using a HP-6890 (Hewlett Packard, U.S.A.) spectrometer with a DB-5MS fused silica capillary column (60 m Â 0:32 mm i.d., 0.25 mm film thickness. J and W Scientific, U.S.A.) coupled to a JMS-700 (JEOL, Japan) employing the El-SIM method at 10,000 resolutions. To determine the recovery rate of various Co-PCBs, mixtures of 13 Clabeled PCBs were used.
The concentration of dioxins was shown on a fat basis, after which TEQs were calculated using WHOtoxic equivalency factor (TEF) values. 7) In this study, values under the detection limits are reported as zero.
Statistical analysis. Differences in median dioxin concentrations among the various maternal samples were investigated for statistical significance using the Mann-Whitney U test.
Results

PCDD/PCDF concentrations and toxic equivalency quantity (TEQ) determinations
The PCDD/PCDF TEQ concentrations in maternal samples are shown in Table 1 . The average TEQs of PCDDs/PCDFs from circulating maternal blood (n ¼ 4), cord blood (n ¼ 16), and the placenta (n ¼ 21), were 26 pg-TEQ/g-fat, 15 pg-TEQ/g-fat, and 31 pg-TEQ/gfat respectively. The average TEQs of PCDDs/PCDFs from milk taken 3-10 d, and one month after delivery were 16 pg-TEQ/g-fat and 18 pg-TEQ/g-fat respectively. Samples of adipose tissue (n ¼ 20) yielded an average TEQ of 16 pg-TEQ/g-fat. Figure 1 shows the percentages of the TEQs of the various congeners to the total TEQ (the TEQ percentages). The TEQ percentages of 1,2,3,7,8-PeCDD and 1,2,3,6,7,8-HxCDD were 50% and 25% respectively in all maternal samples, except for the placenta (Fig. 1) . Within the placenta, the TEQ percentages of 1,2,3,7,8-PeCDD approached 80%. A relatively high TEQ percentage of OCDD was found in the blood. The TEQ percent of PCDFs were high in all The TEOs in maternal samples were calculated using the WHO-TEF for humans. 7) Data were extracted from Table 1 . 
Average minimum maximum Average minimum maximum Average minimum maximum Average minimum maximum Average minimum maximum Average minimum maximum Measurements of Co-PCBs in maternal samples were carried out as described in ''Materials and Methods''. a Values were calculated at ND(Not detected) = zero, b Calculated using the WHO-TEF for humans. 7) maternal samples, particularly the TEQ percentage of 2,3,4,7,8-PeCDF (Fig. 1) . The TEQ percent for 2,3,4,7,8-PeCDF approached 70% in maternal and cord blood, 80% in adipose tissue and milk, and 90% in placental tissue. Thus the relative proportion of each congener differs among different maternal samples.
Co-PCB concentrations and toxic equivalency quantity (TEQ) determinations
The Co-PCB TEQ concentrations in maternal samples are shown in Table 2 . The average TEQs of Co-PCBs from circulating maternal blood (n ¼ 5), cord blood (n ¼ 22), and the placenta (n ¼ 13) were 9.3 pg-TEQ/gfat, 2.3 pg-TEQ/g-fat, and 1.2 pg-TEQ/g-fat respectively. The average TEQs of Co-PCBs in fat from milk taken 3-10 days (n ¼ 6), and one month (n ¼ 4), after delivery were 5.4 pg-TEQ/g-fat and 8.8 pg-TEQ/g-fat respectively. Samples of adipose tissue (n ¼ 12) yielded an average TEQ of 7.7 pg-TEQ/g-fat. The TEQ percentages for 3,3 0 ,4,4 0 ,5-PeCB (#126), 2,3,3 0 ,4,4 0 ,5-HxCB (#156), and 2,3 0 ,4,4 0 ,5-PeCB (#118) approached 60%, 20%, and 10% respectively, in all maternal samples (Fig. 2) . Although the TEQ percentages of each Co-PCB congener were similar among all maternal tissues, large differences in the total TEQ values for each tissue were observed.
Comparison of dioxin concentrations in the various maternal samples
Although there were individual differences, large differences were observed in the congener profiles and total TEQ concentrations of various maternal samples. The TEQ concentrations of dioxins in maternal tissue are shown in Fig. 3 .
As shown in Fig. 3 , from highest to lowest, the PCDD TEQ concentrations were as follows: placenta > maternal blood > breast milk (taken 3-10 d after delivery) > breast milk (taken one month after delivery) > adipose tissue > cord blood. From highest to lowest, the PCDF TEQ concentrations were as follows: placenta > mother's blood > cord blood > breast milk (taken 3-10 d after delivery) > breast milk (taken one month after delivery) > adipose tissue.
Non-ortho PCB TEQ concentrations exhibited the following trend, from highest to lowest: breast milk (taken one month after delivery) > mother's blood > The TEOs in maternal samples were calculated using the WHO-TEF for humans.
7)
Fig. 2. Mean TEQ Percentages of Co-PCB Congeners in Maternal Samples. The TEOs in maternal samples were calculated using the WHO-TEF for humans. 7) Data were extracted from Table 2. adipose tissue > breast milk (taken 3-10 days after delivery) > cord blood > placenta. Mono-ortho TEQ concentrations exhibited the following trend: mother's blood > adipose tissue > breast milk (taken one month after delivery) > breast milk (taken 3-10 d after delivery) > cord blood > placenta. When TEQ concentrations were listed from highest to lowest, the order in which PCDDs, PCDFs, and CoPCBs were placed differed greatly among different tissues, implying that they might have different affinities for different tissues. It is interesting that the TEQ concentrations of PCDDs/PCDFs were greatest in the placenta, while Co-PCBs demonstrated the lowest TEQ concentration in the placenta. It is generally thought that mother's milk excretes dioxins that have accumulated in adipose tissue. Therefore, longer lactation periods might be associated with decreased concentrations of dioxins in mother's milk. An increase in Co-PCB concentrations, however, was observed after one month of lactation in this study. This is addressed in the discussion.
Discussion
Transfer of dioxins to the unborn child via the placenta Transfer of dioxins from maternal to cord blood occurs via the placenta. The placenta has an important function in removing waste products from the embryo, as well as carbon dioxide, while transporting nutrients and oxygen to the unborn child via cord blood. Often this requires active transport against a concentration gradient, but transfer of toxic substances from maternal plasma across the placenta is thought to occur by simple diffusion. The placental permeability of a toxic substance is important to know when evaluating its toxicity to the embryo, such as its teratogenicity. Transfer of toxic substances from maternal to fetal plasma across the placenta is similar to transfer across other biological membranes. Toxic substances that are not protein-bound and non-dissociative cross the placenta more easily. Furthermore, toxic substances with a high log Kow show greater ease of transfer to the unborn child. In addition, transfer of dioxins across the placenta is restricted by molecular size. 26) We examined the contribution of each of these parameters to transfer across the placenta.
Next we examined the tendencies of dioxins to accumulate within the placenta. 2,3,7,8-TeCDD, 1,2,3,7,8-PeCDD, and 2,3,4,7,8-PeCDF were found in significantly greater amounts in the placenta (n ¼ 21 for PCDDs/PCDFs, n ¼ 13 for Co-PCBs), than in the maternal blood (n ¼ 4 for PCDDs/PCDFs, n ¼ 5 for Co-PCBs) (p < 0:05). Thus there was specific accumulation of these three congeners in the placenta. A similar tendency was found Patients A, B, C, and D, for whom there are not only dioxin data for the blood but also for the placenta (Fig. 4A) . This might be due to the presence of the Ah receptor in the human placenta. 27) It is thought that these three congeners might accumulate in the placenta, more so than other congeners, due to their high affinity for the Ah receptor. Affinity for the Ah receptor is an important consideration when evaluating the toxicity of a dioxin, and it now serves as the basis for determination of the TEF.
7) The TEFs of 2,3,7,8- TeCDD, 1,2,3,7,8-PeCDD, and 2,3,4,7,8 -PeCDF are 1, 1, and 0.5, respectively. These values are higher than those of other dioxin congeners, which range from 0.1 to 0.00001. It has been suggested that congeners showing high affinity for the Ah receptor thus accumulate in the placenta.
Next we examined whether the transfer of dioxins from maternal blood to cord blood was restricted by the placenta. The following congeners were found at significantly greater concentrations in maternal blood (n ¼ (Fig. 4B) . Thus the transfer of these dioxin congeners from maternal to cord blood was somehow restricted. But since complete transfer of HpCDDs and OCDD to cord blood was observed, molecular size might not be the only determinant of ease of transfer. Restriction of transfer based on molecule size was thus not confirmed in this research.
In addition, log Kow are also associated with ease of transfer of dioxins across the placenta. It is thought that chemicals with high log Kow transfer more easily across the placenta. Moreover, transfer of dioxins across the placenta is also related to the concentration of free dioxins in maternal blood. 2,3,7,8-TeCDD exists mostly bound to lipoprotein (80%), as well as other plasma proteins (15%) and red blood cells (5%) in the blood. 11, 13) OCDD exists bound to lipoprotein (45%) and other plasma proteins (50%) in the blood.
12) It is thought that Co-PCBs bind to the thyroxine binding protein (e.g., thyroxine binding globulin; TBG, transthyretin; TTR) since they are similar in structure to thyroxine (T 4 ) and triiodothyronine (T 3 ). 28, 29) Thus dioxins exist in different states within the blood. Since dioxins are transported by proteins other than lipids, the rate of dioxin transfer from maternal to cord blood might be determined by a number of different variables. For example, dioxins bound to plasma proteins might be unable to cross the placenta. As a result, dioxin concentrations may be greater in maternal than in cord blood.
Dioxin profiles of maternal blood, adipose tissue, and food Dioxins, which are lipophilic and stable, accumulate throughout the food chain. Consequently, food ingestion is the main source of dioxin exposure in humans who are at the top of the food chain. 9, 10) In order to evaluate the extent of dioxin exposure in humans, a number of surveys have been performed in various countries to determine PCDD/PCDF and dioxin-like PCB dietary intake. In Japan, Tsutsumi et al. 10) have studied daily dietary intake of PCDDs/PCDFs and dioxin-like PCBs based an analysis of diets throughout the country. Dioxins in food are distributed to organs via the blood after ingestion, after which they accumulate primarily in the liver and adipose tissue. Similar distributions of dioxin accumulation have been noted in a number of laboratory animals. 13) Hence it is thought that the concentrations and congener profiles of dioxins in human samples probably reflect the pattern of food The TEOs in maternal blood, placenta, and cord blood were calculated using the WHO-TEF for humans. 7) contamination in the local environment. We examined the exposure situation of dioxins using adipose tissue in, which dioxins accumulate, maternal blood, which is expected to reflect dioxins in adipose tissue and meals, and data from the Ministry of the Health and Welfare of Japan. 30) In the present study, the dioxin congener profiles in adipose tissue and blood were similar to those of seafood, although different TEQ concentrations were observed (Fig. 5). 1,2,3 , each of which showed high levels of accumulation in adipose tissue and blood, were also present in high concentrations in seafood. In the past, PCBs were used in the production of a number of industrial materials, and thus they have accumulated widely in the environment. High concentrations of three of the congeners mentioned above have been noted in fish in Tokyo Bay. Furthermore, high concentrations of these congeners have been observed in the livers of birds that prey on fish in Tokyo Bay. 31) It has been suggested that Co-PCBs were accumulated in process of the food The TEOs in maternal blood and adipose tissue were calculated using the WHO-TEF for humans. 7) The daily dietary intake (in the Kansai area) is quoted from the Ministry of the Health and Welfare of Japan. 30) chain. This result supports the conclusion of Tsutsumi et al. 10) that high exposure to dioxins occurs through ingestion of fish and shellfish in Japan. But 32) Thus congener percentages within the body might differ from those of food due to preferential metabolism and excretion of some congeners, such as 2,3 0 ,4,4 0 ,5-PeCB (#118), compared to others, such as 2,3,3 0 ,4,4 0 ,5-HxCB (#156). In humans, the half-lives of Co-PCBs have been observed to range from 1.5 to 5.7 years, depending on the number of chlorine atoms in the Co-PCBs. 33) This agrees with the observation that 2,3,3 0 ,4,4 0 ,5-HxCB (#156), which has more chlorine atoms than 2,3 0 , 4,4 0 ,5-PeCB (#118), takes longer to be metabolized and therefore tends to remain in the body. In addition, intestinal absorption of dioxins might be influenced by other substances in the diet, as well as by the number of chlorine atoms. 34) Transfer of dioxins to infants via breast milk Dioxins have been identified in maternal milk. 14, 18) In general, it is thought that they are excreted from the body through lactation and hence that the dioxin content of breast milk decreases with time. 16, 20) Dioxins absorbed through food accumulate primarily within adipose tissue in the body. 13) Fatty acids mobilized from adipose tissue are used for synthesis of milk fat in the mammary gland. Thus, dioxins within adipose tissue are thought to transfer to breast milk in this manner.
Dioxin concentrations within breast milk 3-10 d and one month after delivery were compared using median values of distribution and the Mann-Whitney U test (p < 0:05). The values were not significantly different, and thus we could not confirm a decrease in the dioxin concentration of breast milk after one month. Furthermore, while we observed a decrease in PCDDs/PCDFs, we did not observe a decrease in Co-PCBs after one month of lactation in three cases after comparing breast milk obtained 3-10 d and one month after delivery (Fig. 6) . These congeners were detected in high concentrations in seafood which was investigated by the Ministry of the Health and Welfare of Japan. 30) When fatty acids (e.g., palmitic acid, stearin acid, and oleic acid) in food enter the intestine, they form chylomicrons, after which they are absorbed and enter the lymph. Thereafter, they are transferred to the blood and taken to the mammary glands. It is thought that dioxins in food travel to the mammary gland in much the same way. Thus dioxin concentrations in breast milk might be influenced by the type of food ingested.
Conclusions
Our results with regard to background levels of dioxin exposure in Japan suggest several things:
1. Congeners showing high toxic equivalency factor accumulate in the placenta. This result emphasizes the importance of further investigation of the mechanism by which dioxins are transferred from the mother to the fetus.
2. The dioxin congener profiles of seafood were similar to those of maternal blood in Japan. This result supports the theory that dioxin exposure is mainly via food in humans. Hence it might be possible to predict dioxin exposure in humans based on the dioxin concentrations and congener profiles of food in the local environment.
3. Based on the results of this study, dioxins in maternal milk are influenced not only by the adipose tissue but also by another factor. Hence it is also important further examine to the transfer of dioxins via breast milk from mothers to infants.
